Less is Better? Effectiveness of a Short Local Vibration Protocol on Neuromuscular Function

NCT ID: NCT07344298

Last Updated: 2026-01-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-02-15

Study Completion Date

2028-01-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Local vibration is a non-invasive neuromuscular stimulation modality used in training and rehabilitation for its effects on neuromuscular function, particularly its ability to induce nervous adaptations. Its passive application is particularly useful in cases of motor deficit or immobilization.

Several studies, including our own, have shown that vibration protocols over several weeks can induce significant gains in muscle strength, particularly in the knee extensors. However, the parameters of application remain heterogeneous, particularly with regard to the duration of the interventions.

With this in mind, a prospective controlled study is being conducted in healthy subjects, comparing four modalities of local vibration intervention targeting the knee extensors: an intensive vibration protocol over 5 consecutive days (1 session of 30 or 60 minutes per day) and a protocol spread over 4 weeks at a rate of 3 weekly sessions of 30 or 60 minutes). The objective is to evaluate and compare their immediate and delayed effects on force production and corticospinal properties. The results of this study will thus help optimize recommendations regarding the use of local vibration in muscle strengthening and neuromuscular reconditioning strategies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volonteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a single-center, randomized, controlled trial comparing four groups of healthy volunteers following a protocol involving local vibration applied to the knee extensor muscles of the dominant leg. Two groups will follow a short-term intervention program consisting of 5 consecutive days of 30 or 60 minutes of vibration (5 sessions), while the other two will benefit from a program spread over 4 weeks at a rate of 3 sessions per week of 30 or 60 minutes of vibration (a total of 12 sessions).
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group "5 days and 30 min"

Participants will follow a protocol involving local vibration applied to the quadriceps muscle for 5 consecutive days, at a rate of one 30-minute session per day.

Group Type EXPERIMENTAL

Local vibration protocol

Intervention Type DEVICE

The vibrations will be delivered using the Vibramoov Physio device, positioned directly on the quadriceps muscle. The participant will be seated comfortably and will remain at rest throughout the session. The vibration settings will be set to an amplitude of 1 mm and a frequency of 100 Hz.

Group "5 days and 60 min"

Participants will follow a protocol involving local vibration applied to the quadriceps muscle for 5 consecutive days, at a rate of one 60-minute session per day.

Group Type EXPERIMENTAL

Local vibration protocol

Intervention Type DEVICE

The vibrations will be delivered using the Vibramoov Physio device, positioned directly on the quadriceps muscle. The participant will be seated comfortably and will remain at rest throughout the session. The vibration settings will be set to an amplitude of 1 mm and a frequency of 100 Hz.

Group "4-weeks and 30 min"

Participants will follow a protocol involving local vibration applied to the quadriceps muscle over a period of 4 weeks, with 3 weekly sessions of 30 minutes each, for a total of 12 sessions.

Group Type EXPERIMENTAL

Local vibration protocol

Intervention Type DEVICE

The vibrations will be delivered using the Vibramoov Physio device, positioned directly on the quadriceps muscle. The participant will be seated comfortably and will remain at rest throughout the session. The vibration settings will be set to an amplitude of 1 mm and a frequency of 100 Hz.

Group "4-weeks and 60 min"

Participants will follow a protocol involving local vibration applied to the quadriceps muscle over a period of 4 weeks, with 3 weekly sessions of 60 minutes each, for a total of 12 sessions.

Group Type EXPERIMENTAL

Local vibration protocol

Intervention Type DEVICE

The vibrations will be delivered using the Vibramoov Physio device, positioned directly on the quadriceps muscle. The participant will be seated comfortably and will remain at rest throughout the session. The vibration settings will be set to an amplitude of 1 mm and a frequency of 100 Hz.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Local vibration protocol

The vibrations will be delivered using the Vibramoov Physio device, positioned directly on the quadriceps muscle. The participant will be seated comfortably and will remain at rest throughout the session. The vibration settings will be set to an amplitude of 1 mm and a frequency of 100 Hz.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Vibramoov Physio

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women,
* Aged between 18 and 45,
* With a body mass index between 20 and 25 kg/m²,
* Who have received detailed information about the study and have co-signed the consent form with the investigator,
* Who are affiliated with or entitled to social security coverage.

Exclusion Criteria

* Subjects with chronic cardiovascular, neuromuscular, bone, metabolic, and/or inflammatory conditions,
* Personal history and/or risk factors for thrombosis,
* Subjects undergoing antidepressant treatment,
* Subjects who have taken corticosteroid treatment in the last 3 months,
* Use of neuroactive substances likely to alter corticospinal excitability (hypnotics, antiepileptics, psychotropic drugs, muscle relaxants) during the study period,
* History of bone or ligament trauma to the lower limbs within the last 12 months,
* Unable to perform the physical efforts required for the study,
* Engaging in intense and unusual physical activity, including competitive sports, in the month preceding and during the protocol,
* Presence of a skin lesion at the site where the vibrator is to be placed,
* Simultaneous participation in another interventional medical trial,
* Pregnant and breastfeeding women
* Subjects unable to understand the purpose and conditions of the study, unable to give their consent,
* Subjects deprived of their liberty or subject to legal protection such as guardianship
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laboratoire Interuniversitaire de Biologie de la Motricité

OTHER

Sponsor Role collaborator

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Léonard FEASSON, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

CHU de Saint Etienne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Saint-Etienne

Saint-Etienne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Léonard FEASSON, MD, PhD

Role: CONTACT

(0)477120383 ext. +33

Thomas LAPOLE, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Léonard FEASSON, MD, PhD

Role: primary

(0)477120383 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ANSM

Identifier Type: OTHER

Identifier Source: secondary_id

25CH170

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Vibration Training Approach in Liver Cirrhosis
NCT06337656 NOT_YET_RECRUITING NA